Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.006 EUR | 0.00% | 0.00% | -40.00% |
2021 | Ovoca Bio : Enrolls First Patient in Phase 2 Trial for Hypoactive Sexual Desire Disorder Treatment | MT |
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.89M 4.56M |
---|---|---|---|---|---|
Net income 2021 | -5M -4.66M | Net income 2022 | -5M -4.66M | EV / Sales 2021 | - |
Net cash position 2021 | 6.59M 6.14M | Net cash position 2022 | 3.7M 3.45M | EV / Sales 2022 | - |
P/E ratio 2021 |
-2.23
x | P/E ratio 2022 |
-0.87
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 47.54% |
Current month | +20.00% | ||
1 month | +20.00% | ||
3 months | -40.00% | ||
6 months | -60.00% | ||
Current year | -40.00% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.006 | 0.00% | 0 |
24-04-24 | 0.006 | 0.00% | 30,000 |
24-04-23 | 0.006 | 0.00% | 0 |
24-04-22 | 0.006 | 0.00% | 0 |
24-04-19 | 0.006 | 0.00% | 0 |
Real-time Irish S.E., April 25, 2024 at 11:55 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-40.00% | 524K | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.82% | 22.02B | |
-17.84% | 20.9B | |
-9.14% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- OVXA Stock